Clinical Pulsed Magnetic Therapy Suppliers & Manufacturers

SEERS Medical design and manufacture in the UK a wide range of patient examination furniture for various medical procedures including Podiatry, Gynaecology, Ultrasound, Dialysis, Day Care, Showering, Phlebotomy, Lymphoedema, Physiotherapy, ...

ReproNovo, established in 2021, is a company with a focus on reproductive medicine and women's health. The team, composed of experts with years of experience, is dedicated to developing innovative therapeutic solutions targeting male and female ...

The Scinogy team is dedicated to making your clinical results a commercial reality. Provide optimized solutions for the development and manufacture of high quality, affordable cell therapies. Choosing manufacturing technologies and a scale-up ...

Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. ...

BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by ...

Lightcast is developing a cell manipulation platform that utilises tiny spots of light to control thousands of cells and reagents at once, enabling game-changing workflows for the pharmaceutical industry. With applications ranging from ...

Tissue Genesis, LLC offers best-in-class, clinical-grade cell therapy solutions. Its state-of-the-art Icellator® X is a high-performance, point-of-care device that efficiently extracts adult stem cells from a small sample of autologous adipose ...

PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...

ViGeneron is based on our passion to deliver gene therapy innovations and advances to people in need. Our proprietary science solves major limitations in current gene therapy approaches. At ViGeneron we are dedicated to developing innovative gene ...

We are a team of passionate, experienced individuals who work every day to improve the lives of patients. Led by an expert team of biotechnology and pharmaceutical professionals, we are united by one goal—to stop cancer from ever derailing patients’ ...

Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions. Stemedica has developed a proprietary ...

Oncomfort Digital Sedation is a non-pharmacological therapy for relieving patients’ pain and anxiety before, during and after medical procedures. This digital therapy combines clinical hypnotherapy and integrative therapeutic techniques through ...

Diamyd Medical is a clinical-stage diabetes company active in the field of pharmaceutical development. We develop two novel disease-modifying drugs: the antigenspecific immunotherapy Diamyd and the oral regenerative and immunomodulatory therapeutic ...

Science in Action (SIA) is a boutique preclinical contract research organization (CRO) founded in 2010 by immunologist Raanan Margalit. SIA is GLP-accredited for toxicology studies in multiple areas. SIA has extensive experience in tailor-made ...

Hemostemix (TSX V:HEM; OTCQB:HMTXF) is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. Hemostemix’s proprietary platform technology is based on more ...

Deep Lens is a digital healthcare company focused on a groundbreaking approach to faster recruitment of the best-suited cancer patients to clinical trials. VIPER, Deep Lens’ integrated cloud platform, provides care teams with visibility and ...

Lupagen is a privately held early stage biotech company developing first-in-class bedside enabled cell & gene therapies (CAR-T cell, gene editing and immunotherapy products) based on their patent-pending bedside point-of-care C and GT production and ...

Jericho Sciences is developing novel antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 ...

Galapagos discovers, develops and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through to Phase 3 programs in inflammation, fibrosis, and other indications. Our first medicine is approved and ...

ASC Therapeutics is a fully incorporated biopharmaceutical company focusing on the development of curative therapeutic products that are enabled by our proprietary gene editing platform, TARGATT and other gene editing technologies developed after 12 ...